Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

RenovoRx Inc. (RNXT)

  • Company Report
  • April 01, 2023, 01:10 UTC
  • 39

New SEC Form for RenovoRX, Inc.

Comment Full text

Actinium Pharmaceuticals Inc. (ATNM)

  • Company Report
  • April 01, 2023, 00:19 UTC
  • 41

New SEC Form for Actinium Pharmaceuticals, Inc.

Comment Full text

CNS Pharmaceuticals Inc. (CNSP)

  • Company Report
  • April 01, 2023, 00:15 UTC
  • 40

New SEC Form for CNS Pharmaceuticals, Inc.

Comment Full text

Creative Medical Technology Holdings Inc. (CELZ)

  • Company Report
  • April 01, 2023, 00:05 UTC
  • 39

New SEC Filing for Creative Medical Technology Holdings Inc. (NASDAQ:CELZ)

Comment Full text

Checkpoint Therapeutics Inc. (CKPT)

  • Company Report
  • April 01, 2023, 00:00 UTC
  • 44

New SEC Form for Checkpoint Therapeutics, Inc.

Comment Full text

180 Life Sciences Corp. (ATNF)

  • Company Report
  • April 01, 2023, 00:00 UTC
  • 39

New SEC Form for 180 Life Sciences Corp.

Comment Full text

Titan Pharmaceuticals Inc. (TTNP)

  • Company Report
  • March 31, 2023, 23:55 UTC
  • 44

New SEC Form for Titan Pharmaceuticals, Inc.

Comment Full text

Spectrum Pharmaceuticals Inc (SPPI)

  • Company Report
  • March 31, 2023, 23:55 UTC
  • 41

New Form 10-K for Spectrum Pharmaceuticals, Inc.

Comment Full text

Soligenix Inc. (SNGX)

  • Company Report
  • March 31, 2023, 23:50 UTC
  • 43

New SEC Filing for Soligenix Inc. (NASDAQ:SNGX)

Comment Full text

Aridis Pharmaceuticals Inc. (ARDS)

  • Company Report
  • March 31, 2023, 23:50 UTC
  • 45

New SEC Filing for Aridis Pharmaceuticals (NASDAQ:ARDS)

Comment Full text
  • Previous
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next

Search

News categories

  • Technical Exchange News(9040)
  • Event(407)
  • SEC News(142696)
  • FDA Approval(8415)
  • Company Report(721)
  • Business News(99922)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin